首页> 外国专利> Proteìna, except the existing natural, polinucleotìdeo substantially pure, antibody prepared by a process comprising the step of injecting a pharmacologically acceptable preparation.Vector for express

Proteìna, except the existing natural, polinucleotìdeo substantially pure, antibody prepared by a process comprising the step of injecting a pharmacologically acceptable preparation.Vector for express

机译:除了现有的天然,基本上纯的,基本上纯的,多核苷酸的抗体外,其蛋白的制备方法包括注射药理学可接受的制剂的步骤。表达DRR-1小鼠的载体,载体,宿主细胞DDR-1小鼠,DRR-人的1个,人的DRR-2个,人的DDR-3个,人的DRR-4个,人的DRR-5个,DRR-6个人的重组体。测试化合物的测试方法结合或激活与蛋白质(DRR)相连的背根神经节特异受体的能力

摘要

"Proteu00ecna, except the existing natural, polinucleotu00ecdeo substantially pure, antibody prepared by a process comprising the step of injecting a pharmacologically acceptable preparation.Vector for expressing the DRR - 1 mouse, vector, host cell DDR - 1 mouse, DRR - 1 of the human being, DRR - 2 of the human being, DDR - 3 of the human being, DRR - 4 of the human being, DRR - 5 of the human being,DRR - 6 human recombinant.Process for testing a test compound on its ability to bind to or activate a specific receptor of dorsal root ganglia attached to the proteu00ecna g (DRR) "this invention isDirected the new receptors linked to protein G that are found predominantly in the dorsal root ganglia.The invention covers both the receptor proteins and nucleic acids which encode the proteins.Angiotensin I and III and calcium signaling in cells transformed with DNA encoding the receptor.In addition, the present invention is directed to processes and compositions which use the receptors.
机译:除了现有的天然的,基本上纯的,基本上纯的,多核苷酸的抗体外,该抗体是通过包括注射药理学可接受的制剂的步骤制备的。用于表达DRR-1小鼠的载体,载体,宿主细胞DDR-1小鼠,人的DRR-1,人的DRR-2,人的DDR-3,人的DRR-4,人的DRR-5,DRR-6人重组。待测化合物结合或激活与蛋白质(DRR)相连的背根神经节的特异性受体的能力。“本发明针对与蛋白质G相关的新受体,该受体主要在背根神经节中发现。本发明涵盖受体蛋白和编码该蛋白的核酸。血管紧张素I和III以及用编码该受体的DNA转化的细胞中的钙信号传导。另外,本发明涉及使用该受体的方法和组合物。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号